FineHeart

FineHeart Successfully Raises €15 million Series B funding With Industrial and Independent Investors

FineHeart Successfully Raises €15 million Series B funding With Industrial and Independent Investors The First In Human implantation of the ICOMS FLOWMAKER® is assured following this financing French Version English Version

FineHeart breaks new ground with successful removal of the ICOMS FLOWMAKER® in a 90-day in-vivo trial

FineHeart breaks new ground with successful removal of the ICOMS FLOWMAKER® in a 90-day in-vivo trial Towards a new standard for device indication: Implantation for temporary or permanent use. French Version English Version

Wireless Transcutaneous Energy Transfer (TET) System for powering its ICOMS FLOWMAKER® Heart Pump

Wireless Transcutaneous Energy Transfer (TET) System for powering its ICOMS FLOWMAKER® Heart Pump A major step and a critical milestone achieved prior to First In Human clinical trials. We are delighted to have succeeded in this major technological advancement proving the ability to power a Cardiac Assist device via an intelligent and minimally invasive TET… Poursuivre la lecture de Wireless Transcutaneous Energy Transfer (TET) System for powering its ICOMS FLOWMAKER® Heart Pump

Miniaturized Heart Pump

Miniaturized Heart Pump FineHeart Achieves Milestone For its Miniaturized Heart Pump Technology with Successful Completion of 30-Day Preclinical Study This in vivo study is a significant milestone as we work towards first-in-human clinical trials and prove ICOMS FLOWMAKER® technology as a potential game-changer in saving patients from heart failure Arnaud Mascarell Founder & Chief Executive… Poursuivre la lecture de Miniaturized Heart Pump

FineHeart Webinar June 25, 2020

FineHeart was delighted to host its ICOMS webcast on June 25th 2020 with leading US cardiac KOLs Professors Mandeep Mehra and Frank Pagani.

Publié le
Catégorisé comme Events, news

FineHeart Completes First Successful Chronic In-Vivo Study of its ICOMS Device Intended for the Treatment of Severe Heart Failure

FineHeart, a French medical device company, today announced the success of a seven-day preclinical study to evaluate its Implantable Cardiac Output Management System (ICOMS), the first fully Intra-Ventricular Flow Accelerator synchronized to the native heartbeat to restore natural heart pumping capacity.

MedTech Strategist – An LVAD works in synchrony with the heart

Thank you to Mary Stuart for this great article in Medtech Strategist. If you want to learn more about FineHeart and why the ICOMS will become the new standard in severe Heart Failure treatment, here it is !

FineHeart, one of the most innovative companies in 2019

For the second year, 100 brevets.tech reveals its ranking of the most innovative startup in France. FineHeart is one of them, and ranks in the top 20 !

Innovative Companies Featured at the Emerging Medtech Summit

The Emerging Medtech Summit is held annually at The Ritz-Carlton Laguna Niguel in Dana Point CA. The event has a single mission: to bring together the most innovative medtech startups, active investors, and strategic buyers to deal-make and collaborate about the future of Medtech industry.

FierceMedTech's 2018 Fierce 15

FierceMedTech named FineHeart as one of its fierce 15 MedTech companies for 2018! Click here for more!

Click here to check out FineHeart press release on U.S. BusinessWire